Skip to main content
Log in

Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Among gut microbiota-derived metabolites, trimethylamine-N-oxide (TMAO) is receiving increased attention due to its possible role in the carcinogenesis of colorectal cancer (CRC). In spite of numerous reports implicating TMAO with CRC, there is a lack of empirical mechanistic evidences to concretize the involvement of TMAO in the carcinogenesis of CRC. Possible mechanisms such as inflammation, oxidative stress, DNA damage, and protein misfolding by TMAO have been discussed in this review in the light of the latest advancements in the field. This review is an attempt to discuss the probable correlation between TMAO and CRC but this linkage can be concretized only once we get sufficient empirical evidences from the mechanistic studies. We believe, this review will augment the understanding of linking TMAO with CRC and will motivate researchers to move towards mechanistic study for reinforcing the idea of implicating TMAO with CRC causation.

Key points

• TMAO is a gut bacterial metabolite which has been implicated in CRC in recent years.

• The valid mechanistic approach of CRC causation by TMAO is unknown.

• The article summarizes the possible mechanisms which need to be explored for validation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

source foods such as fish, eggs, and meat. Although dietary TMAO can skip the gut microbiome processing before absorption but choline and carnitine must be processed to TMA by gut bacteria. TMA can be processed and converted to TMAO by the hepatic enzyme, FMO3 after it has been formed. The liver can expel dietary and endogenously formed TMAO, which can be absorbed by extrahepatic tissues or excreted in urine (adapted with permission from Ref. Cho et al. 2017, © 2016 Elsevier)

Fig. 3
Fig. 4

Similar content being viewed by others

References

Download references

Funding

The study was funded by grant from SERB-DST (Grant No. CRG/2018/002957) and the Core grant of the National Institute of Immunology, New Delhi, India. PRS and AK are thankful to the Department of Biotechnology for Indo-Russia (DBT/IC-2/Indo-Russia/2017-19/02), and Indian Council of Medical Research (ICMR), India (34/13/2019-TF/Nano/BMS) for financial support. 

Author information

Authors and Affiliations

Authors

Contributions

AK and PRS designed the study. RJ, ND, and AKY collected data and produced the initial draft of the manuscript. MS, RS, and DV contributed to drafting the manuscript. All authors have read and proved the final submitted manuscript.

Corresponding author

Correspondence to Pratima R. Solanki.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jalandra, R., Dalal, N., Yadav, A.K. et al. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer. Appl Microbiol Biotechnol 105, 7651–7660 (2021). https://doi.org/10.1007/s00253-021-11582-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-021-11582-7

Keywords

Navigation